Is it true that after using ritexitinib, my hair grows but my hair doesn’t stop falling out?

During the clinical use of Ritlecitinib, some patients reported significant regeneration of hair, eyebrows, eyelashes and even body hair after taking the drug for weeks to months. It is particularly effective in the treatment of autoimmune hair loss diseases such as alopecia areata. However, the statement that "intermittent hair loss still occurs after hair grows" is also circulated among some users. This phenomenon is not uncommon in medicine, and the reason may be closely related to the drug's mechanism of action, fluctuations in individual immune status, and fluctuations in the course of the disease.

Ritexitinib intervenes in the abnormal immune mechanism that causes alopecia areata by selectively inhibitingJAK3 and TEC family kinases, thereby promoting the return of hair follicles to the normal growth cycle. However, alopecia areata is a chronic and relapsing autoimmune disease. Even if it is relieved with drug intervention, it does not rule out that there will be certain fluctuations in the condition. Especially under the influence of psychological stress, hormone fluctuations, infection and other triggers, localized or sporadic hair loss may still be triggered. Therefore, even if significant hair regrowth occurs during medication, sometimes hair sparseness or hair loss may still occur in some areas.

In addition, it has also been clinically observed that some patients show "loss first and then hair growth" in the early stage of the drug's effect That is, mild hair loss occurs in the early stage of taking the drug. This is one of the processes in which aging hair is replaced by new hair follicles, and is not necessarily a sign of insufficient drug efficacy. It is worth mentioning that in most cases of successful treatment, as long as the patient adheres to the treatment and follows up regularly, the vast majority of regenerated hair can maintain a stable state and the degree of hair loss gradually decreases. Therefore, the phenomenon of "hair loss after using ritexitinib" should be scientifically evaluated based on the patient's medication cycle, hair loss pattern and individual differences. It cannot be generalized, nor does it mean that the treatment has failed. The doctor will appropriately extend the course of treatment or adjust the dose based on the efficacy evaluation to achieve the goals of stabilizing regeneration and reducing recurrence.

Reference materials:https://www.litfulo.com/